2016 - Health Care for Women Over 40

Interesting GYN Cases: Panel Discussion (Rx = .5 hr.) - Q&D (Rx = .25 hr.) - Faculty Panel

Apr 13, 2016 3:45pm ‐ Apr 13, 2016 5:00pm

Expiration Date: May 2, 2019


Credits: None available.

Standard: $21.00

Description

Learning Objectives:

  • To present their patients with a new way of assessing risk benefit ratios with any therapy (discussion of absolute vs. relative risk).
  • To evaluate their patients’ needs, to reevaluate symptoms, and put them into the context of their overall medical health.
  • To provide some historical background on the evolution of a particular therapy that may be suggested; and to suggest what may be upcoming in the future for alternatives.

Speaker(s):

Disclosures

  • Mary Minkin, MD:

    Disclosure:

    Pfizer
    Novo Nordisk
    Shionogi
    Vertical Pharmaceuticals
    Enzymatic (Nature's Way)
    Noven pharmaceuticals

    Relationship:

    Consultant
    Consultant
    Consultant
    Consultant
    Consultant
    Consultant

  • Anita Nelson, MD:

    Disclosure:

    Agile Pharmaceutical, ContraMed, Merck
    Allergan, Agile, Aspen Pharma, Bayer, Merc
    Allergan, Agile, Bayer, ContraMed, Female Health
    Merck, MicroCHIPS Biotech, Pharmanest

    Relationship:

    Research/Grants
    Speakers Bureau/Honoraria
    Advisory Board/Honoraria
    Advisory Board/Honoraria

Credits

  • 0.75 - Pharmacology
  • 1.75 - Physician
  • 1.75 - RN / NP (All RNs/Nurses except CA RNs)
  • 1.75 - CA RN/CA BRN

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content